The Psychoneuroimmunology of Insomnia: Response to a Vaccine Challenge
The Psychoneuroimmunology of Insomnia: Response to a Vaccine Challenge
批准号:
7300856
负责人:
Wilfred R Pigeon
金额:
$16.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-01 至 2010-07-31
关键词:
AffectAgeAntibodiesAntibody FormationArousalBiometryBloodCardiovascular DiseasesChronic InsomniaClassificationClinicalCognitiveColumbidaeCommunitiesConditionConsumptionDailyDevelopmentDiagnosticDiseaseEnrollmentEpidemiologic StudiesFatigueFemaleFosteringFunctional disorderGenerationsGoalsHPSE geneHealthHealth StatusHealthcareHeart RateHepatitis BHepatitis B VaccinationHepatitis B VaccinesHypertensionImmune responseImmune systemImmunityImmunocompetenceImpaired cognitionIncidenceIndividualInternationalInvestigationK-Series Research Career ProgramsLongevityMajor Depressive DisorderMeasuresMedicalMinorityMorbidity - disease rateObstructive Sleep ApneaOrganOutcomePathway interactionsPatient Self-ReportPatientsPhysiologicalPopulationPremenopausePrevalenceProcessProgram DevelopmentPsychoneuroimmunologyPurposeQuality of lifeRateResearchResearch PersonnelResearch Project GrantsRiskRisk FactorsSamplingSleepSleep DeprivationSleep DisordersSleeplessnessStructureSubstance abuse problemSymptomsTestingTrainingTraining ProgramsTreatment ProtocolsUpper armVaccinationVaccinesWomanagedbaseblood glucose regulationcareerdesigndiariesdisease classificationdisturbance in affecthypothalamic-pituitary-adrenal axisimmune functionindexinginterestmenmortalityprogramsresearch studyresponsesizeskills
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Despite its extraordinary prevalence, increasing incidence across the lifespan, and consequences, the pathophysiology of insomnia and, specifically, the pathways by which morbidity risk is conferred, have been relatively unstudied. The specific goal for this K-Award is to engage in a program of training and developing research that will allow the applicant to blend psychoneuroimmunology (PNI) and insomnia research, and to foster a program of investigation that seeks to delineate how two perpetuating processes of insomnia (hyperarousal and homeostatic dysregulation) affect health outcomes in general, and immune function in particular. The development program detailed in this application is structured to provide the applicant training in PNI, biostatistics, grantsmanship, the ethical conduct of research, and how one engages with minority communities. The specific aim for the proposed research project is to ascertain whether chronic insomnia is associated with a blunted adaptive immune response to an experimental challenge. This study uses a two-group, parallel arm study of 50 pre-menopausal female subjects aged 30-50 (25 with chronic insomnia [Pis] and 25 good sleepers [GSs]) to assess whether insomnia is associated with a blunted antibody response to a Hepatitis B vaccine challenge. Each subject will receive the established 3-part vaccine regimen, with blood draws to determine protective antibody levels following each administration. The central hypothesis to be tested is that Pis will have lower antibody titers (a continuous measure) and lower sero-conversion rates (a dichotomous measure) than GSs following the 1st and 2nd vaccinations. In addition to the specific assessment of immunocompetence, sleep continuity will be assessed daily with sleep diaries; health status will be assessed weekly with symptom checklists. These assessments will occur over a three month period. The value of the proposed career training program and the related research resides in the development of the PI as an individual with the skills and background to bridge traditionally separate domains of investigation, and its capacity to operationally define immunocompetence in a manner' that is likely to be directly related to health outcomes, to do so in a clinical population believed to be at risk for significant medical morbidity, and with a condition that becomes increasingly pronounced with aging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Addressing Hazardous and Harmful Alcohol use Through an Adapted CBT Sleep Intervention
-
批准号:10592944
-
项目类别:
-
资助金额:$22.14万
-
财政年份:2023
-
负责人:Wilfred R Pigeon
-
依托单位:
An Adjunctive Behavioral Sleep Intervention to Prevent Veteran Suicides
-
批准号:8783006
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Wilfred R Pigeon
-
依托单位:
The Psychoneuroimmunology of Insomnia: Response to a Vaccine Challenge
-
批准号:7676872
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2007
-
负责人:Wilfred R Pigeon
-
依托单位:
The Psychoneuroimmunology of Insomnia: Response to a Vaccine Challenge
-
批准号:7473950
-
项目类别:
-
资助金额:$13.0万
-
财政年份:2007
-
负责人:Wilfred R Pigeon
-
依托单位:
Treatment of Insomnia Secondary to Chronic Pain
-
批准号:6836963
-
项目类别:
-
资助金额:$4.73万
-
财政年份:2004
-
负责人:Wilfred R Pigeon
-
依托单位:
Treatment of Insomnia Secondary to Chronic Pain
-
批准号:7117611
-
项目类别:
-
资助金额:$5.2万
-
财政年份:2004
-
负责人:Wilfred R Pigeon
-
依托单位:
Treatment of Insomnia Secondary to Chronic Pain
-
批准号:6946832
-
项目类别:
-
资助金额:$4.99万
-
财政年份:2004
-
负责人:Wilfred R Pigeon
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: